Guidance for clinical trials for children and adolescents with chronic hepatitis C.

Guidance for clinical trials for children and adolescents with chronic hepatitis C.

Item
http://www.wikidata.org/entity/Q39817353
Efficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and meta-analysisIs liver biopsy still needed in children with chronic viral hepatitis?Pegylated interferon alfa and ribavirin for children with chronic hepatitis CTreatment of children with chronic viral hepatitis: what is available and what is in store.Treatment of chronic viral hepatitis C in children and adolescents: UK experience.Polymorphisms in the IFNL3/IL28B gene and hepatitis C: from adults to children.Natural history and response to treatment of HCV infection among Egyptian survivors of childhood malignancy.Vertical genotype 1 HCV infection treated successfully in the second year of life: a case report.Pegylated IFN-α-2a and ribavirin in the treatment of hepatitis C infection in children.Progression of liver diseasesAssociation of IL28B polymorphisms with virological response to peginterferon and ribavirin therapy in children and adolescents with chronic hepatitis C.Long-term outcome of hepatitis C virus infections acquired after pediatric liver transplantation.Current treatment options and response rates in children with chronic hepatitis C.Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin.
P2860

Guidance for clinical trials for children and adolescents with chronic hepatitis C.

Item
http://www.wikidata.org/entity/Q39817353
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Guidance for clinical trials for children and adolescents with chronic hepatitis C.
@en
Guidance for clinical trials for children and adolescents with chronic hepatitis C.
@nl
type
label
Guidance for clinical trials for children and adolescents with chronic hepatitis C.
@en
Guidance for clinical trials for children and adolescents with chronic hepatitis C.
@nl
prefLabel
Guidance for clinical trials for children and adolescents with chronic hepatitis C.
@en
Guidance for clinical trials for children and adolescents with chronic hepatitis C.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Guidance for clinical trials for children and adolescents with chronic hepatitis C.
@en
P2093
P304
P31
P356
10.1097/MPG.0B013E3181F6F09C
P407
P433
P478
P50
P577
P698
P921